Subscribe to receive our Floor Reports covering all the action on the Texas House and Senate floor!
No significant fiscal implication to the State or units of local government is anticipated.
A reduction in the number of advisory committees could result in savings, to the degree such committees are not reestablished in rule. The bill would also combine the Pharmaceutical and Therapeutics Committee and the Drug Utilization Review Board which could result in savings, by consolidating the vendor contracts that support the separate committees. This analysis assumes that the agencies could implement provisions of the bill with existing resources.
The bill would amend chapters in the Government Code, Human Resources Code, and Health and Safety Code by abolishing the following advisory committees:
The bill sets forth provisions stating the STAR Kids Managed Care Advisory Committee and Intellectual and Developmental Disability System Redesign Advisory Committee would be abolished after the one-year anniversary of HHSC’s implementation of transition plans. 23 additional advisory committees would be abolished on the effective date of Article 2. The bill would also establish the Drug Utilization Review Board.
The bill would require the executive commissioner of the Health and Human Services Commission (HHSC) to establish and maintain advisory committees to consider issues and solicit public input across all major areas of the health and human services system, including:
Chapter 2110 of the Government Code would apply to the establishment of
advisory committees under Section 531.012 of the Government Code.
Each of the following state agencies or systems would be required to provide funds to support the Texas Institute of Health Care Quality and Efficiency (TIHCQE) and implement Chapter 1002 of the Health and Safety Code:
Transferring duties of extraneous advisory committees to the Health and Human Services Commission (HHSC) would consolidate government oversight. This is in alignment with the principle of limited government. We support SB 277.
The second chamber sponsor is Representative J.D. Sheffield.